[go: up one dir, main page]

NO20063293L - Farmasoytiske forbindelser - Google Patents

Farmasoytiske forbindelser

Info

Publication number
NO20063293L
NO20063293L NO20063293A NO20063293A NO20063293L NO 20063293 L NO20063293 L NO 20063293L NO 20063293 A NO20063293 A NO 20063293A NO 20063293 A NO20063293 A NO 20063293A NO 20063293 L NO20063293 L NO 20063293L
Authority
NO
Norway
Prior art keywords
pharmaceutical compounds
pharmaceutical
disclosed
compounds
pharmaceutical compositions
Prior art date
Application number
NO20063293A
Other languages
English (en)
Inventor
Susan K Heimbecher
Jim H Kou
Irina Kazakevich
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20063293L publication Critical patent/NO20063293L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives anvendbare farmasøytiske sammensetninger.
NO20063293A 2003-12-19 2006-07-14 Farmasoytiske forbindelser NO20063293L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53156103P 2003-12-19 2003-12-19
PCT/US2004/042616 WO2005060981A2 (en) 2003-12-19 2004-12-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NO20063293L true NO20063293L (no) 2006-07-14

Family

ID=34710234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063293A NO20063293L (no) 2003-12-19 2006-07-14 Farmasoytiske forbindelser

Country Status (15)

Country Link
US (3) US20060009504A1 (no)
EP (1) EP1701699B1 (no)
JP (1) JP2007514758A (no)
KR (1) KR20060111581A (no)
CN (1) CN100528162C (no)
AT (1) ATE516011T1 (no)
AU (1) AU2004303425C1 (no)
BR (1) BRPI0417205A (no)
CA (1) CA2550071A1 (no)
MX (1) MXPA06007102A (no)
NO (1) NO20063293L (no)
NZ (1) NZ547557A (no)
PL (1) PL380665A1 (no)
WO (1) WO2005060981A2 (no)
ZA (1) ZA200604874B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409133B8 (pt) 2003-04-08 2021-05-25 Progenics Pharm Inc preparações farmacêuticas estavéis compreendendo metilnaltrexona
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US20090041839A1 (en) * 2007-05-23 2009-02-12 Beasley Martin W Pharmaceutical compositions for the treatment of pain
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
KR101982482B1 (ko) 2010-03-11 2019-05-27 와이어쓰 엘엘씨 메틸날트렉손의 경구 제형 및 친유성 염
WO2012127472A1 (en) * 2011-03-22 2012-09-27 Mapi Pharma Ltd. Process and intermediates for the preparation of preladenant and related compounds
CN106365221B (zh) * 2016-11-09 2019-04-19 烟台史密得机电设备制造有限公司 一种金刚烷单季铵盐阳离子型三元复合驱采出水除油剂
CN117603148A (zh) 2017-05-05 2024-02-27 探针技术开发及商业化中心 双官能螯合物的药代动力学增强及其用途
KR20200004861A (ko) 2017-05-05 2020-01-14 퓨전 파마슈티칼즈 인크. Igf-1r 모노클로날 항체 및 그의 용도
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
US5935584A (en) * 1994-01-13 1999-08-10 Elizabeth Arden Company Vitamin C delivery system
ATE364374T1 (de) * 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
US6326390B1 (en) * 1998-08-25 2001-12-04 King Pharmaceuticals Reseach And Development, Inc. Use of adenosine A3 receptor antagonists to inhibit tumor growth
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6921825B2 (en) * 1998-09-16 2005-07-26 King Pharmaceuticuals Research & Development, Inc. Adenosine A3 receptor modulators
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
WO2000071163A1 (en) * 1999-05-24 2000-11-30 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP4100865B2 (ja) * 1999-12-13 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 三環式縮合異項環化合物、その製造法およびその医薬
EP1283839B1 (en) 2000-05-26 2005-04-20 Schering Corporation Adenosine a2a receptor antagonists
MY124864A (en) * 2001-10-15 2006-07-31 Schering Corp Adenosine a2a receptor antagonists
US6916811B2 (en) * 2001-11-30 2005-07-12 Schering Corporation Adenosine A2a receptor antagonists
BR0304963A (pt) * 2002-05-30 2004-09-28 King Pharmaceuticals Res & Dev Compostos, composição farmacêutica, e, métodos para modular a atividade de adenosina em um mamìfero, e para tratar um mamìfero sofrendo de ou suscetìvel às doenças
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same

Also Published As

Publication number Publication date
AU2004303425B2 (en) 2009-03-26
US20060009504A1 (en) 2006-01-12
WO2005060981A2 (en) 2005-07-07
PL380665A1 (pl) 2007-03-05
KR20060111581A (ko) 2006-10-27
AU2004303425A1 (en) 2005-07-07
EP1701699A2 (en) 2006-09-20
AU2004303425C1 (en) 2010-02-18
US20080293734A1 (en) 2008-11-27
CN100528162C (zh) 2009-08-19
WO2005060981A3 (en) 2005-12-29
BRPI0417205A (pt) 2007-02-06
MXPA06007102A (es) 2006-08-23
CN1893921A (zh) 2007-01-10
ATE516011T1 (de) 2011-07-15
EP1701699B1 (en) 2011-07-13
NZ547557A (en) 2010-07-30
US20110207740A1 (en) 2011-08-25
JP2007514758A (ja) 2007-06-07
CA2550071A1 (en) 2005-07-07
ZA200604874B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
DE602004021120D1 (de) Photopolymerisierbare zusammensetzung.
FR2862654B1 (fr) Composition amylacee filmogene
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
NO20074037L (no) Farmasoytiske formuleringer med vedvarende frigivelse
SE0301372D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
SE0302305D0 (sv) Novel Compounds
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
DE10393374D2 (de) Zusammensetzung
DK1587478T3 (da) Farmaceutisk sammensætning
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1615640T3 (da) Antineoplastiske sammensætninger
DE602004004388D1 (de) Verdickbare zusammensetzungen
NO20063393L (no) Farmasoytiske preparater
SE0301650D0 (sv) Novel compounds
DK1611115T3 (da) Benzothiazolderivatforbindelser, sammensætninger og anvendelser deraf
SE0500163L (sv) Sammansättning
NO20063293L (no) Farmasoytiske forbindelser
EA200801414A1 (ru) Кальцилитические соединения
DK1646425T3 (da) Parasitisk sammensætning
EP1561467A4 (en) COMPOSITION FOR RECOVERING DAMAGED SKIN
NO20034952D0 (no) Farmasöytiske forbindelser
ATE365529T1 (de) Schweisshemmende zusammensetzungen
NO20044164L (no) Farmasoytiske sammensetninger
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application